<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>8664067</identifier>
<setSpec>1130-0108</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Ronda Gasulla, F A</dc:author>
<dc:author>Martín Herrera, A</dc:author>
<dc:author>López de Medrano, V</dc:author>
<dc:author>Ortega González, E</dc:author>
<dc:author>de Lelis, F P</dc:author>
<dc:author>Gil Egea, M</dc:author>
<dc:author>Herrera Ballester, A</dc:author>
<dc:author>Ballester Belda, E</dc:author>
<dc:description xml:lang="en">Pancreatic involvement has been studied in 70 HIV infected patients, in diverse stages, that were treated with didanosine (ddI), both as monotherapy or associated to zidovudine; 38% of patients presented adverse reaction that obliged to withdraw the medication: pancreatitis (4%), hyperamylasemia (21%) and abdominal pain and/or diarrhea (12%). The possible causes in presentation of adverse effects were evaluated: route of infection, stage of HIV infection, use of pentamidine or trimethoprim-sulfamethoxazole for preventing Pneumocystis carinii pneumonia, administration of ddI in monotherapy or in combined form with zidovudine, time of treatment and level of CD4 lymphocytes. The outcome of adverse effects is related significantly only with the most advanced stage of HIV infection.</dc:description>
<dc:type>Comparative Study</dc:type>
<dc:language>es</dc:language>
<dc:date>1996 Feb </dc:date>
<dc:title xml:lang="es">Afectación pancreática en pacientes VIH tratados con didanosina (DDI).</dc:title>
<dc:title xml:lang="en">[Pancreatic disease in patients with HIV treated with didanosine (DDI)].</dc:title>
<dc:publisher>Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva</dc:publisher>
</metadata>
</record>
</pubmed-document>
